Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection.

Hernandez, Antonio; Patil, Naeem K; Stothers, Cody L; Luan, Liming; McBride, Margaret A; Owen, Allison M; Burelbach, Katherine R; Williams, David L; Sherwood, Edward R; Bohannon, Julia K

Hernandez, Antonio; Patil, Naeem K; Stothers, Cody L; Luan, Liming; McBride, Margaret A; Owen, Allison M; Burelbach, Katherine R; Williams, David L; Sherwood, Edward R; Bohannon, Julia K.

Afiliación

Hernandez A; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: antonio.hernandez@vumc.org.
Patil NK; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Stothers CL; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Luan L; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
McBride MA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Owen AM; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Burelbach KR; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Williams DL; Department of Surgery, East Tennessee State University, James H. Quillen College of Medicine, Johnson City, TN, USA.
Sherwood ER; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bohannon JK; Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

Pharmacol Res ; 150: 104502, 2019 12.

Article en En | MEDLINE | ID: mdl-31689522

Asunto(s)

Adyuvantes Inmunológicos/uso terapéutico; Resistencia a la Enfermedad/inmunología; Receptor Toll-Like 4/agonistas; Animales; Humanos; Inmunidad Innata; Control de Infecciones; Infecciones/inmunología; Receptor Toll-Like 4/inmunología

Palabras clave

3D(6-acyl)-PHAD® (CID 136212447); 3D-PHAD® (CID 136212443); Aminoalkyl glucosamine 4-phosphate; CRX-527 (CID 9877226); Endotoxin tolerance; Glycopyranoside Lipid A (CID 131846120); Hexaacyl monophosphoryl lipid A (CID 10877033); Innate immunity; Lipopolysaccharide; Lipopolysaccharide (CID: 11970143); Metabolic reprogramming; Monophosphoryl lipid A; Neoseptin 3 (CID 77461013); Neoseptins; Phosphorylated hexaacyl disaccharides; Toll-like receptor 4; Ugi

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adyuvantes Inmunológicos / Receptor Toll-Like 4 / Resistencia a la Enfermedad Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google